Legato Capital Management LLC Novo Cure LTD Transaction History
Legato Capital Management LLC
- $718 Million
- Q4 2024
A detailed history of Legato Capital Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Legato Capital Management LLC holds 36,460 shares of NVCR stock, worth $800,661. This represents 0.15% of its overall portfolio holdings.
Number of Shares
36,460
Previous 55,567
34.39%
Holding current value
$800,661
Previous $868,000
25.12%
% of portfolio
0.15%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$266 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$259 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$195 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$106 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$60.2 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.3B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...